| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 34 |
| 1 | RISANKIZUMAB-RZAA | 27 |
| 2 | UPADACITINIB | 23 |
| 3 | PREDNISONE | 20 |
| 4 | ACETAMINOPHEN | 19 |
| 5 | ACETAMINOPHEN 500MG | 14 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 14 |
| 7 | ASPIRIN | 14 |
| 8 | ASPIRIN 325 MG | 14 |
| 9 | ASPIRIN 81 MG | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRACE ELEMENTS INJECTION 4 | 1 | 0.0714 |
| 1 | TRAVOPROST INTRACAMERAL | 1 | 0.0085 |
| 2 | ERAVACYCLINE | 1 | 0.0034 |
| 3 | BACLOFEN INJECTION | 9 | 0.0029 |
| 4 | TOLCAPONE | 1 | 0.0028 |
| 5 | PEGUNIGALSIDASE ALFA | 1 | 0.0027 |
| 6 | INFLIXIMAB-DYYB | 9 | 0.0026 |
| 7 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 2 | 0.0026 |
| 8 | CORTISOL | 1 | 0.0025 |
| 9 | PSYLLIUM HUSK | 3 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 1 | Corticosteroid [EPC] | 37 |
| 2 | Interleukin-23 Antagonist [EPC] | 32 |
| 3 | Janus Kinase Inhibitor [EPC] | 24 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 15 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Osmotic Laxative [EPC] | 12 |
| 9 | Vitamin C [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | Gadolinium-based Contrast Agent [EPC] | 2 | 0.0004 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 3 | 0.0003 |
| 5 | Interleukin-23 Antagonist [EPC] | 32 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 7 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Antiseptic [EPC] | 1 | 0.0002 |